| scholarly article | Q13442814 |
| P50 | author | Heinrich Kovar | Q41462089 |
| Raphaela Schwentner | Q86823360 | ||
| P2093 | author name string | Dietmar Fuchs | |
| Sophie Erhardt | |||
| Javier Alonso | |||
| Michel Goiny | |||
| Maximilian O Kauer | |||
| Florian Kromp | |||
| Dave N T Aryee | |||
| Anna M Katschnig | |||
| Cornelia N Mutz | |||
| P2860 | cites work | Identification of the Ah Receptor Nuclear Translocator Protein (Arnt) as a Component of the DNA Binding Form of the Ah Receptor | Q24336486 |
| Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35 | Q24338794 | ||
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| Endotoxin-Induced Tryptophan Degradation along the Kynurenine Pathway: The Role of Indolamine 2,3-Dioxygenase and Aryl Hydrocarbon Receptor-Mediated Immunosuppressive Effects in Endotoxin Tolerance and Cancer and Its Implications for Immunoparalysis | Q26765777 | ||
| Understanding the role of the kynurenine pathway in human breast cancer immunobiology | Q26773472 | ||
| The second European interdisciplinary Ewing sarcoma research summit--A joint effort to deconstructing the multiple layers of a complex disease | Q26775306 | ||
| Targeting the indoleamine 2,3-dioxygenase pathway in cancer | Q26775471 | ||
| Twenty Years on: What Do We Really Know about Ewing Sarcoma and What Is the Path Forward? | Q26782649 | ||
| Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase | Q28204166 | ||
| An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor | Q28249782 | ||
| Association of the Ah receptor with the 90-kDa heat shock protein | Q28281332 | ||
| Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism | Q28297392 | ||
| The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity | Q29547693 | ||
| The STATs of cancer--new molecular targets come of age | Q29614601 | ||
| 2,3,7,8-Tetrachlorodibenzo-p-Dioxin and Related Halogenated Aromatic Hydrocarbons: Examination of the Mechanism of Toxicity | Q29618527 | ||
| Ovarian tumors in rats induced by chronic 2,3,7,8-tetrachlorodibenzo-p-dioxin treatment. | Q31463198 | ||
| voom: Precision weights unlock linear model analysis tools for RNA-seq read counts | Q33741687 | ||
| Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling | Q33792422 | ||
| Ah receptor ligands and tumor promotion: survival of neoplastic cells | Q33864770 | ||
| The aryl hydrocarbon receptor (AhR) inhibits vanadate-induced vascular endothelial growth factor (VEGF) production in TRAMP prostates | Q33986252 | ||
| A constitutively active dioxin/aryl hydrocarbon receptor induces stomach tumors | Q34098524 | ||
| The aryl hydrocarbon receptor functions as a tumor suppressor of liver carcinogenesis | Q34128053 | ||
| Expression of tryptophan 2,3-dioxygenase in mature granule cells of the adult mouse dentate gyrus. | Q34154342 | ||
| Endogenous kynurenines as targets for drug discovery and development | Q34156448 | ||
| An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells | Q34187909 | ||
| Kynurenic acid inhibits colon cancer proliferation in vitro: effects on signaling pathways | Q34208593 | ||
| Epigenome mapping reveals distinct modes of gene regulation and widespread enhancer reprogramming by the oncogenic fusion protein EWS-FLI1. | Q34464009 | ||
| Cancer Immunotherapy by Targeting IDO1/TDO and Their Downstream Effectors | Q34913785 | ||
| EWS-FLI1 employs an E2F switch to drive target gene expression. | Q35171620 | ||
| Aryl hydrocarbon receptor ligands in cancer: friend and foe. | Q35458027 | ||
| The aryl hydrocarbon receptor contributes to the proliferation of human medulloblastoma cells | Q35913114 | ||
| Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase | Q35925641 | ||
| Endurance exercise increases skeletal muscle kynurenine aminotransferases and plasma kynurenic acid in humans | Q35974760 | ||
| Transcription of Interleukin-8: How Altered Regulation Can Affect Cystic Fibrosis Lung Disease | Q36139057 | ||
| Monitoring tryptophan metabolism in chronic immune activation | Q36247653 | ||
| Aryl hydrocarbon receptor, cell cycle regulation, toxicity, and tumorigenesis | Q36279973 | ||
| Aryl hydrocarbon receptor: Linking environment to immunity | Q36378234 | ||
| Tryptophan Nutrition and Metabolism: An Overview | Q36919700 | ||
| A molecular function map of Ewing's sarcoma | Q37165799 | ||
| Aryl hydrocarbon receptor antagonism attenuates growth factor expression, proliferation, and migration in fibroblast-like synoviocytes from patients with rheumatoid arthritis | Q37550704 | ||
| The aryl hydrocarbon receptor (AhR) in the regulation of cell-cell contact and tumor growth. | Q37682508 | ||
| An introduction to the molecular basics of aryl hydrocarbon receptor biology | Q37792070 | ||
| An expanding range of targets for kynurenine metabolites of tryptophan | Q38057527 | ||
| Role of aryl hydrocarbon receptor in cancer. | Q38109748 | ||
| bHLH-PAS proteins in cancer | Q38164994 | ||
| Blocking the road, stopping the engine or killing the driver? Advances in targeting EWS/FLI-1 fusion in Ewing sarcoma as novel therapy. | Q38243878 | ||
| High-resolution genome-wide mapping of AHR and ARNT binding sites by ChIP-Seq | Q38322490 | ||
| Dibenzo[A,L]pyrene-induced genotoxic and carcinogenic responses are dramatically suppressed in aryl hydrocarbon receptor-deficient mice | Q38477476 | ||
| Regulatory mechanisms, expression levels and proliferation effects of the FUS-DDIT3 fusion oncogene in liposarcoma | Q38795105 | ||
| Synergistic antitumor effect with indoleamine 2,3-dioxygenase inhibition and temozolomide in a murine glioma model | Q38814416 | ||
| AhR and Arnt differentially regulate NF-κB signaling and chemokine responses in human bronchial epithelial cells | Q38958431 | ||
| Phosphoproteomic profiling reveals IL6-mediated paracrine signaling within the Ewing sarcoma family of tumors | Q38968663 | ||
| Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(pyridyl)ethenyl)indoles as potential anticancer immunomodulators | Q39513318 | ||
| Overexpression of indoleamine 2,3-dioxygenase in human endometrial carcinoma cells induces rapid tumor growth in a mouse xenograft model | Q39916520 | ||
| EWS/FLI1 suppresses retinoblastoma protein function and senescence in Ewing's sarcoma cells | Q40013782 | ||
| Cholecystokinin down-regulation by RNA interference impairs Ewing tumor growth. | Q40145072 | ||
| Reinstalling antitumor immunity by inhibiting tumor-derived immunosuppressive molecule IDO through RNA interference | Q40224792 | ||
| Regulation of CYP1A1 gene expression by the antioxidant tert-butylhydroquinone | Q40297002 | ||
| Characterisation of the kynurenine pathway in skin-derived fibroblasts and keratinocytes. | Q41499706 | ||
| The EWS/FLI Oncogene Drives Changes in Cellular Morphology, Adhesion, and Migration in Ewing Sarcoma | Q42530521 | ||
| AhR: far more than an environmental sensor | Q43207322 | ||
| A constitutively active dioxin/aryl hydrocarbon receptor promotes hepatocarcinogenesis in mice | Q44980767 | ||
| Indoleamine-2,3-dioxygenase in an immunotherapy model for Ewing sarcoma. | Q45572170 | ||
| An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid | Q48898368 | ||
| Simultaneous measurement of serum tryptophan and kynurenine by HPLC | Q61906305 | ||
| Characteristics of interferon induced tryptophan metabolism in human cells in vitro | Q61906378 | ||
| Kynurenic acid in human saliva--does it influence oral microflora? | Q79917706 | ||
| Kynurenic acid synthesis and kynurenine aminotransferases expression in colon derived normal and cancer cells | Q84201033 | ||
| Hexachlorobenzene induces cell proliferation, and aryl hydrocarbon receptor expression (AhR) in rat liver preneoplastic foci, and in the human hepatoma cell line HepG2. AhR is a mediator of ERK1/2 signaling, and cell cycle regulation in HCB-treated | Q85665598 | ||
| P433 | issue | 14 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2063-2075 | |
| P577 | publication date | 2016-06-09 | |
| P1433 | published in | FEBS Letters | Q1388051 |
| P1476 | title | EWS-FLI1 impairs aryl hydrocarbon receptor activation by blocking tryptophan breakdown via the kynurenine pathway | |
| P478 | volume | 590 |
| Q89006309 | EWS-FLI1 reprograms the metabolism of Ewing sarcoma cells via positive regulation of glutamine import and serine-glycine biosynthesis |
| Q102210881 | Functional screening identifies aryl hydrocarbon receptor as suppressor of lung cancer metastasis |
| Q57174958 | Identifying the druggable interactome of EWS-FLI1 reveals MCL-1 dependent differential sensitivities of Ewing sarcoma cells to apoptosis inducers |
| Q41866532 | Kynurenine aminotransferase activity of Aro8/Aro9 engage tryptophan degradation by producing kynurenic acid in Saccharomyces cerevisiae. |
Search more.